Report Detail

Request for Sample of this report

Pharma & Healthcare Global Osteoarthritis Medications Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4514947
    • |
  • 19 February, 2023
    • |
  • Global
    • |
  • 124 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
According to our (Global Info Research) latest study, the global Osteoarthritis Medications market size was valued at USD 9506 million in 2022 and is forecast to a readjusted size of USD 11890 million by 2029 with a CAGR of 3.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
This report is a detailed and comprehensive analysis for global Osteoarthritis Medications market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Osteoarthritis Medications market size and forecasts, in consumption value ($ Million), 2018-2029
Global Osteoarthritis Medications market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Osteoarthritis Medications market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Osteoarthritis Medications market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Osteoarthritis Medications
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Osteoarthritis Medications market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis and Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Osteoarthritis Medications market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
NSAIDs
Corticosteroids
Hyaluronic Acid Injection
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Osteoarthritis Medications product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Osteoarthritis Medications, with revenue, gross margin and global market share of Osteoarthritis Medications from 2018 to 2023.
Chapter 3, the Osteoarthritis Medications competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Osteoarthritis Medications market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Osteoarthritis Medications.
Chapter 13, to describe Osteoarthritis Medications research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Osteoarthritis Medications
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Osteoarthritis Medications by Type
    • 1.3.1 Overview: Global Osteoarthritis Medications Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Osteoarthritis Medications Consumption Value Market Share by Type in 2022
    • 1.3.3 NSAIDs
    • 1.3.4 Corticosteroids
    • 1.3.5 Hyaluronic Acid Injection
    • 1.3.6 Others
  • 1.4 Global Osteoarthritis Medications Market by Application
    • 1.4.1 Overview: Global Osteoarthritis Medications Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Osteoarthritis Medications Market Size & Forecast
  • 1.6 Global Osteoarthritis Medications Market Size and Forecast by Region
    • 1.6.1 Global Osteoarthritis Medications Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Osteoarthritis Medications Market Size by Region, (2018-2029)
    • 1.6.3 North America Osteoarthritis Medications Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Osteoarthritis Medications Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Osteoarthritis Medications Market Size and Prospect (2018-2029)
    • 1.6.6 South America Osteoarthritis Medications Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Osteoarthritis Medications Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Osteoarthritis Medications Product and Solutions
    • 2.1.4 Pfizer Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Recent Developments and Future Plans
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Osteoarthritis Medications Product and Solutions
    • 2.2.4 Johnson & Johnson Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.3 GlaxoSmithKline
    • 2.3.1 GlaxoSmithKline Details
    • 2.3.2 GlaxoSmithKline Major Business
    • 2.3.3 GlaxoSmithKline Osteoarthritis Medications Product and Solutions
    • 2.3.4 GlaxoSmithKline Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.4 Novartis
    • 2.4.1 Novartis Details
    • 2.4.2 Novartis Major Business
    • 2.4.3 Novartis Osteoarthritis Medications Product and Solutions
    • 2.4.4 Novartis Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Novartis Recent Developments and Future Plans
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer Osteoarthritis Medications Product and Solutions
    • 2.5.4 Bayer Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Bayer Recent Developments and Future Plans
  • 2.6 Eli Lilly
    • 2.6.1 Eli Lilly Details
    • 2.6.2 Eli Lilly Major Business
    • 2.6.3 Eli Lilly Osteoarthritis Medications Product and Solutions
    • 2.6.4 Eli Lilly Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Eli Lilly Recent Developments and Future Plans
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Osteoarthritis Medications Product and Solutions
    • 2.7.4 Sanofi Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sanofi Recent Developments and Future Plans
  • 2.8 Horizon Pharma
    • 2.8.1 Horizon Pharma Details
    • 2.8.2 Horizon Pharma Major Business
    • 2.8.3 Horizon Pharma Osteoarthritis Medications Product and Solutions
    • 2.8.4 Horizon Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Horizon Pharma Recent Developments and Future Plans
  • 2.9 Abbott
    • 2.9.1 Abbott Details
    • 2.9.2 Abbott Major Business
    • 2.9.3 Abbott Osteoarthritis Medications Product and Solutions
    • 2.9.4 Abbott Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Abbott Recent Developments and Future Plans
  • 2.10 Mylan
    • 2.10.1 Mylan Details
    • 2.10.2 Mylan Major Business
    • 2.10.3 Mylan Osteoarthritis Medications Product and Solutions
    • 2.10.4 Mylan Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Mylan Recent Developments and Future Plans
  • 2.11 Daiichi Sankyo
    • 2.11.1 Daiichi Sankyo Details
    • 2.11.2 Daiichi Sankyo Major Business
    • 2.11.3 Daiichi Sankyo Osteoarthritis Medications Product and Solutions
    • 2.11.4 Daiichi Sankyo Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Daiichi Sankyo Recent Developments and Future Plans
  • 2.12 TEVA
    • 2.12.1 TEVA Details
    • 2.12.2 TEVA Major Business
    • 2.12.3 TEVA Osteoarthritis Medications Product and Solutions
    • 2.12.4 TEVA Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 TEVA Recent Developments and Future Plans
  • 2.13 Almatica Pharma
    • 2.13.1 Almatica Pharma Details
    • 2.13.2 Almatica Pharma Major Business
    • 2.13.3 Almatica Pharma Osteoarthritis Medications Product and Solutions
    • 2.13.4 Almatica Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Almatica Pharma Recent Developments and Future Plans
  • 2.14 Astellas Pharma
    • 2.14.1 Astellas Pharma Details
    • 2.14.2 Astellas Pharma Major Business
    • 2.14.3 Astellas Pharma Osteoarthritis Medications Product and Solutions
    • 2.14.4 Astellas Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Astellas Pharma Recent Developments and Future Plans
  • 2.15 Tide Pharmaceutical
    • 2.15.1 Tide Pharmaceutical Details
    • 2.15.2 Tide Pharmaceutical Major Business
    • 2.15.3 Tide Pharmaceutical Osteoarthritis Medications Product and Solutions
    • 2.15.4 Tide Pharmaceutical Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Tide Pharmaceutical Recent Developments and Future Plans
  • 2.16 Iroko Pharmaceuticals
    • 2.16.1 Iroko Pharmaceuticals Details
    • 2.16.2 Iroko Pharmaceuticals Major Business
    • 2.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Product and Solutions
    • 2.16.4 Iroko Pharmaceuticals Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Iroko Pharmaceuticals Recent Developments and Future Plans
  • 2.17 Hengrui Pharmaceutical
    • 2.17.1 Hengrui Pharmaceutical Details
    • 2.17.2 Hengrui Pharmaceutical Major Business
    • 2.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Product and Solutions
    • 2.17.4 Hengrui Pharmaceutical Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Hengrui Pharmaceutical Recent Developments and Future Plans
  • 2.18 Abiogen Pharma
    • 2.18.1 Abiogen Pharma Details
    • 2.18.2 Abiogen Pharma Major Business
    • 2.18.3 Abiogen Pharma Osteoarthritis Medications Product and Solutions
    • 2.18.4 Abiogen Pharma Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Abiogen Pharma Recent Developments and Future Plans
  • 2.19 Flexion Therapeutics
    • 2.19.1 Flexion Therapeutics Details
    • 2.19.2 Flexion Therapeutics Major Business
    • 2.19.3 Flexion Therapeutics Osteoarthritis Medications Product and Solutions
    • 2.19.4 Flexion Therapeutics Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Flexion Therapeutics Recent Developments and Future Plans
  • 2.20 Anika Therapeutics
    • 2.20.1 Anika Therapeutics Details
    • 2.20.2 Anika Therapeutics Major Business
    • 2.20.3 Anika Therapeutics Osteoarthritis Medications Product and Solutions
    • 2.20.4 Anika Therapeutics Osteoarthritis Medications Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 Anika Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Osteoarthritis Medications Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Osteoarthritis Medications by Company Revenue
    • 3.2.2 Top 3 Osteoarthritis Medications Players Market Share in 2022
    • 3.2.3 Top 6 Osteoarthritis Medications Players Market Share in 2022
  • 3.3 Osteoarthritis Medications Market: Overall Company Footprint Analysis
    • 3.3.1 Osteoarthritis Medications Market: Region Footprint
    • 3.3.2 Osteoarthritis Medications Market: Company Product Type Footprint
    • 3.3.3 Osteoarthritis Medications Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Osteoarthritis Medications Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Osteoarthritis Medications Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Osteoarthritis Medications Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Osteoarthritis Medications Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Osteoarthritis Medications Consumption Value by Type (2018-2029)
  • 6.2 North America Osteoarthritis Medications Consumption Value by Application (2018-2029)
  • 6.3 North America Osteoarthritis Medications Market Size by Country
    • 6.3.1 North America Osteoarthritis Medications Consumption Value by Country (2018-2029)
    • 6.3.2 United States Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Osteoarthritis Medications Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Osteoarthritis Medications Consumption Value by Type (2018-2029)
  • 7.2 Europe Osteoarthritis Medications Consumption Value by Application (2018-2029)
  • 7.3 Europe Osteoarthritis Medications Market Size by Country
    • 7.3.1 Europe Osteoarthritis Medications Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 7.3.3 France Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Osteoarthritis Medications Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Osteoarthritis Medications Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Osteoarthritis Medications Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Osteoarthritis Medications Market Size by Region
    • 8.3.1 Asia-Pacific Osteoarthritis Medications Consumption Value by Region (2018-2029)
    • 8.3.2 China Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 8.3.5 India Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Osteoarthritis Medications Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Osteoarthritis Medications Consumption Value by Type (2018-2029)
  • 9.2 South America Osteoarthritis Medications Consumption Value by Application (2018-2029)
  • 9.3 South America Osteoarthritis Medications Market Size by Country
    • 9.3.1 South America Osteoarthritis Medications Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Osteoarthritis Medications Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Osteoarthritis Medications Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Osteoarthritis Medications Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Osteoarthritis Medications Market Size by Country
    • 10.3.1 Middle East & Africa Osteoarthritis Medications Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Osteoarthritis Medications Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Osteoarthritis Medications Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Osteoarthritis Medications Market Drivers
  • 11.2 Osteoarthritis Medications Market Restraints
  • 11.3 Osteoarthritis Medications Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Osteoarthritis Medications Industry Chain
  • 12.2 Osteoarthritis Medications Upstream Analysis
  • 12.3 Osteoarthritis Medications Midstream Analysis
  • 12.4 Osteoarthritis Medications Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Osteoarthritis Medications. Industry analysis & Market Report on Osteoarthritis Medications is a syndicated market report, published as Global Osteoarthritis Medications Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Osteoarthritis Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,232.92
    		4,849.38
    		6,465.84
    		537,868.80
    		806,803.20
    		1,075,737.60
    		290,580.00
    		435,870.00
    		581,160.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo